Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2010 09:46 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and BexPharm Enter Into Distribution and Supply Agreement for EpiCeram(R)

DENVER, CO, Feb 22, 2010 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered...
January 07, 2010 06:33 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and BioPro Enter into Distribution and Supply Agreement for EpiCeram(R)

DENVER, Jan 07, 2010 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an...
October 26, 2009 06:46 ET | Source: Ceragenix Pharmaceuticals

Second Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application

DENVER, Oct 26, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today provided an update...
September 09, 2009 06:34 ET | Source: Ceragenix Pharmaceuticals

NIH Issues $2.87 Million Grant for Development of Ceragenin(TM)-Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections

DENVER, Sep 09, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National...
September 01, 2009 06:33 ET | Source: Ceragenix Pharmaceuticals

Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application

DENVER, Sep 01, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a...
August 13, 2009 06:58 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Completes Long-Term Antimicrobial Efficacy Test on Treated Silicone Medical Device

DENVER, Aug 13, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update on its...
July 27, 2009 07:21 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and Megapharm Enter Into Distribution and Supply Agreement for EpiCeram(R)

DENVER, Jul 27, 2009 -- Ceragenix Pharmaceuticals, Inc.("Ceragenix"), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive...
July 09, 2009 07:07 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and Nobel Biocare Enter into Option to License Agreement for Antimicrobial Technology

DENVER, Jul 09, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive...
June 22, 2009 07:15 ET | Source: Ceragenix Pharmaceuticals

National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Infections

DENVER, Jun 22, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at...
May 19, 2009 07:12 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and Davi Enter Into Distribution and Supply Agreement for EpiCeram(R)

DENVER, May 19, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an...